Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eureka Therapeutics, Inc.

http://www.eurekainc.com/

Latest From Eureka Therapeutics, Inc.

Finance Watch: Many Mega-Rounds, Some Smaller VC Deals, But Few In The Middle

Private Company Edition: June’s eight $100m-plus venture capital rounds already outpace the seven each raised in March, April and May, including €255m ($274.2m) for ITM and $200m for Upstream, but while there were five $25m or less VC financings during the past week, mid-sized deals were lacking.

Financing Innovation

Tech Transfer Roundup: MD Anderson, NCI Lead Cancer Alliances

MD Anderson and the US National Cancer Institute lead the way with a series of recent alliances, highlighted in this special edition of Tech Transfer Roundup focused on oncology.

Tech Transfer Round-Up Business Strategies

Finance Watch: SPAC Deals Emerge As IPO Market Goes Quiet Again

Public Company Edition: Direct Biologics, YishengBio and Estrella Biopharma will go public by merging with special purpose acquisition corporations. Also, Vir lands a government contract worth up to $1bn, Idorsia raises CHF164m ($167.4m) in a real estate deal and Adamis reviews alternatives.

Financing Business Strategies

Vaxcell’s NK Cell Therapy Combo Shows Phase IIa Promise In HCC

Korean bioventure’s interim Phase IIa data for locoregional high-dose, autologous natural killer cell therapy in hepatocellular carcinoma in combination with HAIC look "promising," but further safety data awaited.

South Korea Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Eureka (Beijing) Biotechnology Co., Ltd.
UsernamePublicRestriction

Register